Csf biomarkers differentiate between two forms of frontotemporal lobar degeneration

Csf biomarkers differentiate between two forms of frontotemporal lobar degeneration

Play all audios:

Loading...

Access through your institution Buy or subscribe Novel cerebrospinal fluid (CSF) biomarkers can potentially identify patients with one or other of the two main forms of frontotemporal lobar degeneration (FTLD), according to research conducted by John Trojanowski and colleagues at the University of Pennsylvania School of Medicine, USA. Identification of the underlying pathology of FTLD in living patients could “enable early and reliable diagnosis of this disorder, so that therapies, when available, can be given early in the disease process when they are most likely to have the greatest efficacy,” says Trojanowski. > ...five proteins distinguished between FTLD-TDP and FTLD-tau with > 82.6% accuracy... This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support ORIGINAL RESEARCH PAPER * Hu, W. T. _ et al_. Novel CSF biomarkers for frontotemporal lobar degeneration. _Neurology_ doi:10.1212/WNL.0b013e318200d78d Article  CAS  PubMed Central  Google Scholar  Download references Authors * Nick Jones View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Jones, N. CSF biomarkers differentiate between two forms of frontotemporal lobar degeneration. _Nat Rev Neurol_ 7, 4 (2011). https://doi.org/10.1038/nrneurol.2010.189 Download citation * Published: 10 January 2011 * Issue Date: January 2011 * DOI: https://doi.org/10.1038/nrneurol.2010.189 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

Access through your institution Buy or subscribe Novel cerebrospinal fluid (CSF) biomarkers can potentially identify patients with one or other of the two main forms of frontotemporal lobar


degeneration (FTLD), according to research conducted by John Trojanowski and colleagues at the University of Pennsylvania School of Medicine, USA. Identification of the underlying pathology


of FTLD in living patients could “enable early and reliable diagnosis of this disorder, so that therapies, when available, can be given early in the disease process when they are most likely


to have the greatest efficacy,” says Trojanowski. > ...five proteins distinguished between FTLD-TDP and FTLD-tau with > 82.6% accuracy... This is a preview of subscription content,


access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn


more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS


OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support ORIGINAL RESEARCH PAPER * Hu, W. T. _ et al_. Novel CSF biomarkers for frontotemporal


lobar degeneration. _Neurology_ doi:10.1212/WNL.0b013e318200d78d Article  CAS  PubMed Central  Google Scholar  Download references Authors * Nick Jones View author publications You can also


search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Jones, N. CSF biomarkers differentiate between two forms


of frontotemporal lobar degeneration. _Nat Rev Neurol_ 7, 4 (2011). https://doi.org/10.1038/nrneurol.2010.189 Download citation * Published: 10 January 2011 * Issue Date: January 2011 * DOI:


https://doi.org/10.1038/nrneurol.2010.189 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative